TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...
Biohaven Ltd. today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San ...
Read our live updates from CES 2026 in Las Vegas to see the latest consumer gadgetry in all of its chatbot-enabled, ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Morning Overview on MSN
Bluetooth got its name from a Viking king, here’s why
Every time a phone connects to wireless earbuds or a car stereo, a tiny Viking legacy quietly flickers to life. The ...
Morning Overview on MSN
ET might be blinking at us like fireflies, researchers say
Advanced alien civilizations might not be whispering across the cosmos with radio waves at all, but instead flickering like ...
Mohsen Baqery is a Guide Staff Writer from Turkey. With a passion for gaming that borders on obsession, Mohsen thrives on guiding fellow gamers through the most challenging obstacles while exploring ...
SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing ...
Controlling light is an important technological challenge—not just at the large scale of optics in microscopes and telescopes ...
Brain–computer interfaces have been talked about for decades, but they’ve rarely felt practical for everyday users. At CES ...
Newron Pharmaceuticals further expands its intellectual property portfolio for Evenamide with a new EU composition of matter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results